The Institute for Biomolecular Targeting (bioMT) is funded by the IDeA program of the National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS), along with support from Dartmouth College, the Geisel School of Medicine, the Thayer School of Engineering, and the Norris Cotton Cancer Center.
NIH NIGMS requires that bioMT COBRE is acknowledged in publications, abstracts, and presentations if the research being reported on benefitted from bioMT. This applies to the following:
- You (or your PI) has received COBRE funding as a Project Leader or Pilot Project PI
- You have consulted with staff or used services/resources from the Molecular Tools Core and/or Molecular Interactions and Imaging Core.
Suggested wording for citing bioMT:
“Supported by bioMT through NIH NIGMS grant P20-GM113132”
Please remember to comply with the NIH Public Access Policy by:
- Linking your publication from PubMed to NIH NIGMS grant P20-GM113132
- Ensuring that your final peer-reviewed manuscript its submitted to PubMed Central and is assigned a PubMed Central ID (PMCID)
Here are two versions of our bioMT logo we encourage you to use with your presentations!
